EXPLORE PAE PRODUCTS

From set-up and access to hemostasis and including the first and only embolotherapy product with FDA clearance to treat symptomatic BPH via PAE, Merit offers your tools a la carte, or in several convenient packs.

Embosphere PRO™ Prostatic Artery Embolization Kit

SET UP

Prepare and protect your patients efficiently and safely.

PRODUCT RADIAL FEMORAL

Embosphere® Procedure Pack – combines the basic products for any embolization procedure into one convenient pack.

Medallion® Syringes

RadBoard®2 Radial Arm Board

 

Rad Rest®

 

ACCESS

Achieve quick and effective access.

PRODUCT RADIAL FEMORAL

PreludeEASE™ Hydrophilic Sheath Introducer

 

Prelude IDeal™ Hydrophilic Sheath Introducer

 

PreludePRO™ Sheath Introducers

 

EMBOLOTHERAPY

HEMOSTASIS

Achieve controlled hemostasis accurately, quickly, and comfortably.

PRODUCT RADIAL FEMORAL

Safeguard Radial™ Compression Device

 

PreludeSYNC™ Radial Compression Device

 

Safeguard® Pressure Assisted Device

 

PHYSICIAN EDUCATION & RESOURCES

Merit offers an extensive Physician Center to support you in your PAE procedures. Downloadable resources include:

  • Data & Studies
  • Patient Education
  • Referring Physician Materials
  • Reimbursement Support
  • Clinical Resources
  • CMS Look-up Tool

Access the Physician Center

Think PAE™

Learn the minimally invasive technique of Prostatic Artery Embolization (PAE). The ThinkPAE™ education course features numerous cases, didactic presentations including anatomy and patient identification, and hands-on training with simulators utilizing actual PAE cases.

Learn More

 

Interventional Techniques for Prostatic Artery Embolization

PATIENT RESOURCES

Ask4PAE aims to educate patients and their families about PAE as a treatment option for BPH. The program includes Ask4PAE.com, as well as patient brochures and other awareness tactics.

Ask 4 PAE - Prostatic Artery Embolization

For more information please refer to Instructions for Use. Consult product labels and inserts for any indications, contraindications, potential complications, warnings, precautions and directions for use.

References

  1. McWilliams, J. P., Kuo, M. D., Rose, S.C., Bagla, S., Caplin, D. M., Cohen, E. I., Faintuch, S., Spies, J. B., Saad, W. E., Nikolic, B. (2014). Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate. Journal of Vascular and Interventional Radiology, 25: 1349-1351. http://dx.doi.org/10.1016/j.jvir.2014.05.005 http://www.scvir.org/clinical/cpg/SIR_Pos_Statmt_PAE_Benign_dis_Prostate.pdf
  2. Patel, N. D., & Parsons, J. K. (2014). Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian Journal of Urology, 30(2): 170-176. doi: 10.4103/0970-1591.126900
  3. Krista, A. R., Arnold, K. B., Schenk, J. M., Neuhouser, M. L., Weiss, N., Goodman, P., Antvelink, C. M., Penson, D. F., & Thompson, I. M. (2007). Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. The Journal of Urology, 177(4): 1395-1400